Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007423
Filing Date
2022-02-23
Accepted
2022-02-23 17:45:18
Documents
2
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3901
2 EX-24 DOCUMENT attachment1.htm EX-24 4815
  Complete submission text file 0000899243-22-007423.txt   10169
Mailing Address C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
SQUINTO STEPHEN P (Reporting) CIK: 0001231954 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 22665272

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)